| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.54 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.065 | 0.1 |